VAERS reports by lot

GSK Hepatitis A lot EP47E: VAERS reports

45 VAERS reports list lot EP47E as a GSK Hepatitis A vaccine, received between 2021-12-03 and 2024-03-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
0%
Marked serious
0
With a death outcome
20
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular526%
Gastrointestinal526%
Neurological421%
Dermatological (non-injection-site)211%
Thrombotic / Hematological15%
Allergic / Anaphylactic15%
Musculoskeletal15%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan5
Texas4
Illinois4
Wisconsin4
Georgia4
California3
Pennsylvania3
Virginia2
Colorado2
Tennessee2
South Carolina1
Idaho1

Reports by month received

2021-122
2022-011
2022-036
2022-041
2022-051
2022-061
2022-071
2022-081
2022-092
2022-103
2022-111
2022-121
2023-012
2023-029
2023-036
2023-042
2023-051
2023-082
2024-021
2024-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.